US Broker Ratings

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Exploring a 21.56% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the medical instruments and supplies industry, offers a compelling opportunity for investors seeking exposure to the healthcare sector. With a market..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a 59% Potential Upside in Biotech Innovation

Denali Therapeutics Inc. (DNLI), a trailblazer in the biotechnology sector, is capturing investor attention with its robust pipeline aimed at tackling neurodegenerative and lysosomal storage diseases. Headquartered in South San..

Belite Bio, Inc (BLTE) Stock Analysis: A 14.79% Upside Beckons in the Biotech Sector

Belite Bio, Inc (NASDAQ: BLTE) presents a compelling opportunity in the healthcare sector, particularly for investors with an appetite for biotechnology ventures. Founded in 2016 and based in San Diego,..

Certara, Inc. (CERT) Stock Analysis: Unpacking a 22% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT) stands at the crossroads of healthcare innovation and investment opportunity. As a leader in the health information services industry, Certara offers a suite of technology-enabled services..

National HealthCare Corporation (NHC) Stock Analysis: A Closer Look at Its Impressive Revenue Growth and Financial Health

National HealthCare Corporation (NHC), operating in the healthcare sector with a focus on medical care facilities, has garnered attention for its robust revenue growth and financial health. With a market..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring an 80% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX) is a prominent player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $875.57 million, GoodRx offers a..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 17% Potential Upside in Biotech

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a biopharmaceutical innovator focused on developing peptide therapeutics for complex blood disorders and inflammatory diseases, stands out in the biotechnology sector with a market capitalization..

NovoCure Limited (NVCR) Stock Analysis: An Investor’s Look at 81.53% Potential Upside in the Healthcare Sector

For investors with an eye on the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling opportunity. As a specialist in medical devices, NovoCure focuses on innovative solutions for treating..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Standout with 26% Upside Potential

For investors keen on the healthcare sector, PACS Group, Inc. (PACS) presents a compelling opportunity. With a focus on skilled nursing and assisted living facilities, PACS operates a portfolio that..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Strong Buy Ratings Highlight Potential Upside

For investors seeking opportunities in the healthcare sector, Brookdale Senior Living Inc. (NYSE: BKD) presents an intriguing case. With a market capitalization of $3.04 billion, this Brentwood, Tennessee-based company is..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 27% Upside Potential Amidst Strong Revenue Growth

For investors eyeing opportunities within the biotechnology sector, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) presents an intriguing prospect. With a market capitalization of $1.68 billion, this U.S.-based biopharmaceutical company is pushing..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Look at the 46.90% Potential Upside and Cutting-Edge Genetic Medicine Advancements

Beam Therapeutics Inc. (NASDAQ: BEAM) stands at the forefront of biotechnology innovation with its ambitious focus on precision genetic medicines. Headquartered in Cambridge, Massachusetts, this company is making waves in..

Kymera Therapeutics (KYMR) Stock Analysis: Exploring a 64% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is a promising name in the biotechnology industry, drawing significant attention from investors due to its innovative approach and strategic partnerships. Headquartered in Watertown, Massachusetts,..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: 14.83% Potential Upside in CNS and Rare Disease Biotech

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, has captured investor attention with its focus on developing treatments for central nervous system (CNS) disorders and rare..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring a 28% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, presents an intriguing opportunity for investors looking to capitalize on its potential upside. With a market capitalization..

Kiniksa Pharmaceuticals (KNSA): A Promising Biopharma with 27% Upside Potential

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is capturing investor attention with its robust growth trajectory in the biopharmaceutical sector, specializing in developing therapies for cardiovascular diseases and other conditions with unmet..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A 55% Potential Upside in the Medical Device Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC), a dynamic player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to spinal disorder treatments. Headquartered in..

Progyny, Inc. (PGNY) Investor Outlook: Analyzing a Promising 24.43% Potential Upside in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) is making waves in the healthcare sector with its innovative approach to fertility and family-building benefits. As a benefits management company, Progyny offers a comprehensive suite..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating the Upside with Strategic Growth in Rare Disease Therapeutics

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is carving out a niche in the biotechnology sector with its focus on rare diseases, presenting unique opportunities for investors seeking growth in the healthcare..

Alvotech (ALVO) Stock Analysis: Exploring a 315.88% Upside Potential in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based healthcare company, is swiftly gaining traction in the biosimilar medicines sector. With an impressive market capitalization of $1.66 billion, Alvotech is positioning itself as a formidable..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds